https://www.techtarget.com/pharmalifesciences/news/366606610/Bristol-Myers-Ends-Clinical-Program-for-Combination-Drug-Therapy
Bristol Myers Ends Clinical Program for Combination Drug Therapy | TechTarget
Bristol Myers Squibb ends the global clinical development program for their combination drug therapy, bempegaldesleukin (BEMPEG) and Opdivo (nivolumab), in...
combination drug therapybristol myersclinical programendstechtarget
https://www.stjude.org/research/progress/2018/malaria-treatment-improves-leukemia-survival-rates.html
St. Jude scientists discover effective combination therapy for treatment of drug-resistant leukemia...
A drug used to treat malaria was found to hold the key to unlocking the treatment of a rare leukemia.
https://www.uclahealth.org/news/release/combination-therapy-with-experimental-drug-improves-outlook-for-breast-cancer-patients
Combination therapy with experimental drug improves outlook for breast cancer patients | UCLA Health
A combination therapy using an experimental new drug shows significant promise for women with a common type of breast cancer in which estrogen causes their...
https://kffhealthnews.org/morning-breakout/dr00019467/
South African Generic Drug Maker Hopes To Offer Generic Antiretroviral Combination Therapy by End...
South African Generic Drug Maker Hopes To Offer Generic Antiretroviral Combination Therapy by End of Year